Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: A series of 17 cases

References

• Arda B, Yamazhan T, Sipahi OR, Islekel S, Buke C, Ulusoy S. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents 2005;25:414–8.
   PubMed Web of Science ®Google Scholar
• Huang CR, Lu CH, Wu JJ, Chang HW, Chien CC, Lei CB, . Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes. Infection 2005;33:56–60.
   PubMedGoogle Scholar
• Palabiyikoglu I, Tekeli E, Cokca F, Akan O, Unal N, Erberktas I, . Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006;62:94–7.
   PubMed Web of Science ®Google Scholar
• Tunkel AR, van de Beek D, Scheld WM. Acute meningitis. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. 7th. Churchill Livingstone, Elsevier, New York; 2010. 1189–229.
   Google Scholar
• Hardy KJ, Hawkey PM, Gao F, Oppenheim BA. Methicillin-resistant Staphylococcus aureus in the critically ill. Br J Anaesth 2004;92:121–30.
   Google Scholar
• Moellering RC. Pharmacokinetics of vancomycin. J Antimicrob Chemother 1984;14(Suppl D):43–52.
   PubMedGoogle Scholar
• Quintilliani R, Cooper BW. Current concepts in the treatment of staphylococcal meningitis. J Antimicrob Chemother 1988;21:107–12.
   Google Scholar
• Faella F, Pagliano P, Fusco U, Attanasio V, Conte M. Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin resistant strains. Clin Microbiol Infect 2006;12:391–4.
   PubMed Web of Science ®Google Scholar
• Kruse AJ, Peerdeman SM, Bet PM, Debets-Ossenkopp YJ. Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment. Eur J Clin Microbiol Infect Dis 2006;25:135–7.
   PubMedGoogle Scholar
• Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007;41:296–308.
   PubMed Web of Science ®Google Scholar
• Arman D, Sarı N, Ergüt-Sezer B, Ata N, Dizbay M, Hızel K, . A case of methicillin-sensitive Staphylococcus aureus (MSSA) meningitis-cerebritis treated with linezolid. Flora 2009;14:139–43.
   Google Scholar
• Falagas ME, Manta KG, Ntziora F, Vardakas KZ. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006;58:273–80.
   PubMed Web of Science ®Google Scholar
• Villani P, Regazzi MB, Marubbi F, Viale P, Pagani L, Cristini F, . Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002;46:936–7.
   PubMed Web of Science ®Google Scholar
• Viale P, Pagani L, Cristini F, Stefini R, Bergomi R, Colombini P, . Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 2002;34:456–9.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horon TC, Hughes JM. CDC definitions for nosocomial infections. Olmsted RN. APIC infection control and applied epidemiology: principles and practice. St Louis: Mosby; 1996. A1–20.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. M100-S19. Wayne, PA: CLSI; 2009.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. M100-S20. Wayne, PA: CLSI; 2010.
   Google Scholar
• Sipahi OR, Arda B, Yurtseven T, Sipahi H, Ozgiray E, Suntur BM, . Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis. Int J Antimicrob Agents 2005;26:412–5.
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical MIC breakpoints. Available at: http://www.eucast.org/clinical_breakpoints/ (accessed 1 March 2011).
   Google Scholar
• Samra Z, Ofer O, Shmuely H. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin, and other antibiotics. Isr Med Assoc J 2005;7:148–50.
   PubMed Web of Science ®Google Scholar
• Harland S, Tebss SE, Elliott TSJ. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY 333328 in comparison with vancomycin and teicoplanin. J Antimicrob Chemother 1998;41:273–6.
   PubMed Web of Science ®Google Scholar
• Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, . Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect 2007;55:41–8.
   PubMed Web of Science ®Google Scholar
• Calik S, Turhan T, Yurtseven T, Sipahi O, Buke C. Vancomycin versus linezolid in the therapy of experimental methicillin-resistant Staphylococcus aureus meningitis. Abstract P1023. Abstracts of the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Helsinki, 2009.
   Google Scholar
• Moise PA, Sakoulas G, Forrest A, Schentag JJ. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2007;51:2582–6.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Martinez-Martin P, Kennedy PG, Andrew Seaton R, Portegies P, Bojar M, . EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649–59.
   PubMed Web of Science ®Google Scholar